These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36470444)

  • 1. Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors.
    Nikolaev MV; Strashkov DM; Ryazantsev MN; Tikhonov DB
    Eur J Pharmacol; 2023 Jan; 938():175448. PubMed ID: 36470444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical Control of
    Nikolaev MV; Strashkov DM; Ryazantsev MN; Tikhonov DB
    ACS Chem Neurosci; 2021 Sep; 12(18):3347-3357. PubMed ID: 34469111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-Sensitive Open Channel Block of Ionotropic Glutamate Receptors by Quaternary Ammonium Azobenzene Derivatives.
    Nikolaev M; Tikhonov D
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible Control of Native GluN2B-Containing NMDA Receptors with Visible Light.
    Geoffroy C; Berraud-Pache R; Chéron N; McCort-Tranchepain I; Doria J; Paoletti P; Mony L
    ACS Chem Neurosci; 2024 Sep; 15(18):3321-3343. PubMed ID: 39242213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of antagonists for NMDA and AMPA receptors.
    Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
    Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemical approaches to vision restoration.
    Van Gelder RN
    Vision Res; 2015 Jun; 111(Pt B):134-41. PubMed ID: 25680758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate currents in morphologically identified human dentate granule cells in temporal lobe epilepsy.
    Isokawa M; Levesque M; Fried I; Engel J
    J Neurophysiol; 1997 Jun; 77(6):3355-69. PubMed ID: 9212280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+-permeable non-NMDA glutamate receptors in rat magnocellular basal forebrain neurones.
    Waters DJ; Allen TG
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):453-69. PubMed ID: 9508809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A red-shifted, fast-relaxing azobenzene photoswitch for visible light control of an ionotropic glutamate receptor.
    Kienzler MA; Reiner A; Trautman E; Yoo S; Trauner D; Isacoff EY
    J Am Chem Soc; 2013 Nov; 135(47):17683-6. PubMed ID: 24171511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties and H+ sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones.
    Traynelis SF; Cull-Candy SG
    J Physiol; 1991 Feb; 433():727-63. PubMed ID: 1726797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.
    Herrera-Arozamena C; Estrada-Valencia M; Martí-Marí O; Pérez C; de la Fuente Revenga M; Villalba-Galea CA; Rodríguez-Franco MI
    Eur J Med Chem; 2020 Aug; 200():112403. PubMed ID: 32447198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices.
    Moldavski A; Behr J; Bading H; Bengtson CP
    J Physiol; 2020 Feb; 598(4):633-650. PubMed ID: 31876958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fine-tuned azobenzene for enhanced photopharmacology in vivo.
    Gutzeit VA; Acosta-Ruiz A; Munguba H; Häfner S; Landra-Willm A; Mathes B; Mony J; Yarotski D; Börjesson K; Liston C; Sandoz G; Levitz J; Broichhagen J
    Cell Chem Biol; 2021 Nov; 28(11):1648-1663.e16. PubMed ID: 33735619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade by ifenprodil of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions.
    Church J; Fletcher EJ; Baxter K; MacDonald JF
    Br J Pharmacol; 1994 Oct; 113(2):499-507. PubMed ID: 7834201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization.
    Gilling K; Jatzke C; Wollenburg C; Vanejevs M; Kauss V; Jirgensons A; Parsons CG
    J Neural Transm (Vienna); 2007; 114(12):1529-37. PubMed ID: 17728997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, density, and clustering of functional glutamate receptors before and after synaptogenesis in hippocampal neurons.
    Cottrell JR; Dubé GR; Egles C; Liu G
    J Neurophysiol; 2000 Sep; 84(3):1573-87. PubMed ID: 10980028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.